Skip to main content

Zusammenfassung

Erläutert werden alle relevanten Funktionstests mit ausführlicher Darstellung von Indikationen, Kontraindikationen, Nebenwirkungen, Testvorbereitung, Rahmenbedingungen, konkreten Handlungsanleitung der eigentlichen Testdurchführung sowie der Interpretation der Testergebnisse. Es werden immer konkrete Normbereiche und Cut-off-Werte angegeben, auch für besondere Situationen (Geschlecht, Alter, BMI, Pubertätsphasen, Zyklusphasen, akute Erkrankungen, Medikamente etc.). Ein besonderes Merkmal ist die Betonung der Testvorbereitung, -durchführung und -interpretation sowie des interdisziplinären Charakters. Hypothalamische Funktionstests wie Insulin-Hypoglykämie-, Exercise-, Clonidin- und Propranolol-Glukagon-Test sind anspruchsvoll, sowohl in der Durchführung als auch in der Interpretation. Insbesondere die Cut-off-Werte für GH unterliegen ständigen Anpassungen und Einflüssen und sind stets im gesamten klinischen Kontext zu würdigen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Andersson, A.M., Orskov, H., Ranke, M.B., Shalet, S., Skakkebaek, N.E. 1995. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol 132: 340–343.

    Google Scholar 

  2. Corneli, G., Di Somma, C., Prodam, F., Bellone, J., Bellone, S., Gasco, V., Baldelli, R., Rovere, S., Schneider, H.J., Gargantini, L., Gastaldi, R., Ghizzoni, L., Valle, D., Salerno, M., Colao, A., Bona, G., Ghigo, E., Maghnie, M., Aimaretti, G. 2007. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 157: 701–708.

    Google Scholar 

  3. Ho, K.K. 2007. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157: 695–700.

    Article  CAS  PubMed  Google Scholar 

  4. Ghigo, E., Bellone, J., Aimaretti, G., Bellone, S., Loche, S., Cappa, M., Bartolotta, E., Dammacco, F., Camanni, F. 1996. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81: 3323–3327.

    Google Scholar 

  5. Hindmarsh, P.C., Swift, P.G. 1995. An assessment of growth hormone provocation tests. Arch Disease Childhood 72: 362–367; discussion 367-368.

    Google Scholar 

  6. Okada, Y., Watanabe, K., Takeuchi, T. Hata, T., Mikam, H. 1977. Evaluation of propranolol-glucagon test. Acta Endocrinol (Copenh) 86: 243–250.

    Google Scholar 

  7. Andler, W., Bernasconi, S., Giovanelli, G., Biro, G. 1975. Insulin- and propanol-glucagon stimulation tests. Comparison of both methods. Monatsschrift Kinderheilkunde 123: 338–339.

    Google Scholar 

  8. Rochiccioli, P., Enjeaume, P., Dutau, G., Ribot, C., Augier, D. 1976. Stimulation by the propranolol-glucagon test of somatotropin secretion in 71 children. Results, statistical study and comparison with the insulin-arginine test. Arch Francaises Pediatr 33: 453–465.

    Google Scholar 

  9. Scaramuzza, A., Torresani, P., Arisi, D., Rossoni, R. 2000. Seizures following clonidine test for growth hormone reserve: unusual presentation of benign partial epilepsy. J Pediatr Endocrinol Metab 13: 451–452.

    Google Scholar 

  10. Huang, C., Banerjee, K., Sochett, E., Perlman, K., Wherrett, D., Daneman, D. 2001. Hypoglycemia associated with clonidine testing for growth hormone deficiency. J Pediatrics 139: 323–324.

    Google Scholar 

  11. Morris, A.H., Harrington, M.H., Churchill, D.L., Olshan, J.S. 2001. Growth hormone stimulation testing with oral clonidine: 90 minutes is the preferred duration for the assessment of growth hormone reserve. J Pediatr Endocrinol Metab 14: 1657–1660.

    Google Scholar 

  12. Hauffa, B.P. (2014) Wachstumshormontherapie in der Transitionsphase. Endokrinologie-Informationen der DGE, Sonderheft, 2014, S. 9

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schäffler, A. et al. (2015). Hypothalamus. In: Schäffler, A. (eds) Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47480-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-47480-8_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-47479-2

  • Online ISBN: 978-3-662-47480-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics